Quarterly report pursuant to Section 13 or 15(d)

Revision of Prior Period Financial Statements - Summary of Restatement of Balance Sheet (Detail)

v3.21.1
Revision of Prior Period Financial Statements - Summary of Restatement of Balance Sheet (Detail) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
Restatement [Line Items]        
Inventories $ 26,174 $ 25,451    
Current Assets 60,500 45,623    
Total Assets 364,881 353,133    
Accrued and other current liabilities 67,450 55,053    
Current Liabilities 250,702 231,879    
Total Liabilities 335,370 305,804    
Accumulated deficit (743,594) (724,142)    
Shareholders' equity total 29,511 47,329 $ 118,175 $ 352,473
Total Liabilities and Shareholders' Equity 364,881 353,133    
Previously Reported [Member]        
Restatement [Line Items]        
Inventories   30,292    
Current Assets   50,464    
Total Assets   357,974    
Accrued and other current liabilities   56,381    
Current Liabilities   233,207    
Total Liabilities   307,132    
Accumulated deficit   (720,629)    
Shareholders' equity total 50,842 50,842    
Total Liabilities and Shareholders' Equity   357,974    
Adjustment [Member]        
Restatement [Line Items]        
Inventories   (4,841)    
Current Assets   (4,841)    
Total Assets   (4,841)    
Accrued and other current liabilities   (1,328)    
Current Liabilities   (1,328)    
Total Liabilities   (1,328)    
Accumulated deficit   (3,513)    
Shareholders' equity total (3,513) (3,513)    
Total Liabilities and Shareholders' Equity   (4,841)    
Restated [Member]        
Restatement [Line Items]        
Inventories   25,451    
Current Assets   45,623    
Total Assets   353,133    
Accrued and other current liabilities   55,053    
Current Liabilities   231,879    
Total Liabilities   305,804    
Accumulated deficit   (724,142)    
Shareholders' equity total $ 47,329 47,329    
Total Liabilities and Shareholders' Equity   $ 353,133